Test3Bank:
Advanced3Pharmacology3 for3Prescribers31st3Edition3Luu3Kayingo3Latest3
Edition,32024
, Table3of3Contents
Chapter3 1:3 An3 Introduction3 to3 Evidence-Based3 Clinical3 Practice3 Guidelines......................................... 3
Chapter3 2:3 Pharmacokinetics3 /Chapter3:3 Pharmacodynamics .............................................................. 13
Chapter4:3 Pharmacogenetics3 and3 Pharmacogenomics ......................................................................... 25
Chapter3 5:3Pharmacology3 Across3 the3Life3Span ................................................................................. 30
Chapter3 6:3Drug-Therapy3 Prescribing3in 3Special3 Populations.............................................................. 36
Chapter3 7:3Drug3Development3 and3Approval ..................................................................................... 45
Chapter38-Chapter310:3Foundations3of3Prescription3Writing3Chapter39:3ResponsibleControlled-
Substance3Prescribing3Chapter310:3Antibiotic3Stewardship.................................................................. 51
Chapter3 11:3 Applied3Calculations3 for3 Prescribing .............................................................................. 58
Chapter312-:3Promoting3Adherence3With3Pharmacotherapy3II:3System-Specific3and3Patient-
Focused3Prescribing3Chapter313:3Pharmacotherapy3for3Ear,3Nose,3Mouth,3andThroat3Conditions3/Chapte
r314:3Pharmacotherapy3for3 Eye3Conditions......................................................................................... 67
Chapter3 15:3 Pharmacotherapy3 for3 Skin3 Conditions............................................................................. 74
Chapter3 16:3Pharmacotherapy3 for3 Neurologic3 Conditions ................................................................... 81
Chapter3 17:3 Pharmacotherapy3 for3 Cardiovascular3 Conditions ............................................................. 94
Chapter3 18:3 Pharmacotherapy3 for3 Respiratory3 Conditions ................................................................ 106
Chapter319:3Pharmacotherapy3for3Gastrointestinal3Conditions3and3Conditions3RequiringNutritional3Supp
ort .................................................................................................................................................. 117
Chapter3 20:3Pharmacotherapy3 for3 Genitourinary3 Conditions ............................................................. 128
Chapter3 21:3 Pharmacotherapy3for3 Renal,3 Acid–Base,3 Fluid,3 and3Electrolyte3Disorders...................... 133
Chapter3 22:3 Pharmacotherapy3 for3 Musculoskeletal3 and3 Rheumatologic3 Conditions ........................... 146
Chapter3 23:3 Therapeutic3 Applications3 of3 Immunology3 and3 Vaccines................................................ 158
Chapter3 24:3Pharmacotherapy3 for3 Endocrine3 Disorders .................................................................... 163
Chapter3 25:3Pharmacotherapy3 for3 Hematologic3 Disorders ................................................................ 174
Chapter3 26:3 Hematology/Oncology3and3Supportive3 Care3for3 the3Nononcologist................................ 190
Chapter3 27:3Pharmacotherapy3 Related3 to3 Women’s3 Health3Conditions ............................................. 196
Chapter3 28:3 Pharmacotherapy3 Related3 to3 Men’s3 Health3 Conditions .................................................. 211
Chapter3 29:3Pharmacotherapy3 Related3 to3Transgender3 Care ............................................................. 217
Chapter3 30:3 Antimicrobial3 Pharmacotherapy .................................................................................... 224
Chapter3 31:3 Antiretroviral3 Pharmacotherapy .................................................................................... 235
Chapter332:3Psychopharmacology3and3Integrative3Health:3Combined3Treatment3ofPsychiatric3and3Neuro
cognitive3Conditions........................................................................................................................ 247
Chapter3 33:3Pharmacotherapy3for3 Pain3Management ........................................................................ 257
Chapter3 34:3Substance3 Use3Disorder3 III:3Health3Promotion3and3Maintenance ................................... 267
Chapter3 35:3Over-the-Counter3 Medications ...................................................................................... 283
Chapter3 36:3Pharmacotherapy3for3 Obesity ....................................................................................... 291
,Chapter31:3An3Introduction3 to3Evidence-Based3Clinical3Practice3Guidelines
MULTIPLE3CHOICE
• What3is3the3 primary3 purpose3 of3 the3nursing3 assessment?
A. Identifying3 underlying3 pathologic3 conditions
B. Assisting3 the3 physician3 in3identifying3 medical3 conditions
C. Determining3 the3 patients3 mental3status
D. Exploring 3 patient3 responses3 to3 health3 problems
ANS:3D
A3nursing3assessment3is3done3to3identify3the3patients3response3to3health3p
roblems.3During3the3nursing3assessment3phase,3a3comprehensive3informat
ion3base3is3developed3through3a3physical3examination,3nursing3history,3m
edication3history,3and3professional3observation.3Identifying3underlying 3pat
hologic3conditions3and3assisting3the3physician3in3identifying3medical3con
ditions3is3not3part3of3the3nursing3process.3Determining3the3patients3 mental
3status3 is3 one3part3 of3the3 nursing 3 assessment,3 but3 it3 is3 not3the3primary 3p
urpose.
DIF:3Cognitive3Level:3Comprehension
3REF:3dm336 3OBJ:31 3|33 3TOP:3Nursin
g3Process3Step:3Assessment
MSC:3NCLEX3 Client3 Needs3 Category:3 Health3 Promotion3 and3 Maintenance
• What3is3the3 basis3 of3the3NANDA3I3 taxonomy?
A. Functional3 health3patterns
B. Human3 response3patterns
C. Basic3 human3 needs
D. Pathophysiologic3 needs
ANS:3B
The3 NANDA3 I3 taxonomy3 identifies3 human3 response3 patterns.3Functio
nal3components3of3health3patterns3are3limited3to3activity,3fluid3volume,3n
utrition,3self3care,3and3sensory3perception.3Basic3human3needs3comprise3
less3than3merely3health3patterns.3Pathophysiologic3needs3are3 not3part3of
3the3scope3of3NANDA 3I.
, DIF:3Cognitive3Level:3 Knowledge3RE
F:3pp.337-383OBJ:353TOP:
Nursing3Process3Step:3Diagnosis
MSC:3NCLEX3 Client3 Needs3 Category:3 Physiological3 Integrity
• Which3task3 is3included3 in3the3 assessment3 step3of3the3 nursing3 process?
A. Establishing3 patient3 goals/outcomes
B. Implementing3 the3 nursing3 care3 plan3 (NCP)
C. Measuring3 goal/outcome3 achievement
D. Collecting3 and3 communicating3 data
ANS:3D
Data3are3collected3and3communicated3in3the3assessment3phase3of3the3nurs
ing3process.3Establishing3goals3is3the3function3of3planning.
Implementing 3the3NCP3is3the3function3of3implementation.3Measuring3out
come3achievement3is3the3function3of3evaluation.
DIF:3Cognitive3Level:3Comprehension
3REF:3dm336 3OBJ:32 3|33 3TOP:3Nursin
g3Process3Step:3Assessment
MSC:3NCLEX3 Client3 Needs3 Category:3 Health3 Promotion3 and3 Maintenance
• Which3statement3 regarding3 nursing3diagnoses3 is3 accurate?
a. Nursing3diagnoses3 remain3the3same3 for3 as3 long3as3 the3disease3 is3 present.
b. Nursing3 diagnoses3 are3 written3 to3 identify3disease3states.
c. Nursing3diagnoses3 describe3 patient3 problems3 that3 nurses3 treat.
d. Nursing3 diagnoses3 identify3 causes3 related3 to3 illness.
ANS:3C
Diagnostic3statements3identify3problems3a3nurse3is3independently 3able3to3
treat3within3the3scope3of3professional3practice.3Nursing3diagnoses3vary3w
ith3the3changing3condition3of3the3patient.3The3response3patterns3are3uniqu
e3to3the3patient3and3are3not3disease3specific.3Nursing3diagnoses3describe3t
he3patients3human3response3pattern.
DIF:3 Cognitive3 Level:3 Comprehension
Advanced3Pharmacology3 for3Prescribers31st3Edition3Luu3Kayingo3Latest3
Edition,32024
, Table3of3Contents
Chapter3 1:3 An3 Introduction3 to3 Evidence-Based3 Clinical3 Practice3 Guidelines......................................... 3
Chapter3 2:3 Pharmacokinetics3 /Chapter3:3 Pharmacodynamics .............................................................. 13
Chapter4:3 Pharmacogenetics3 and3 Pharmacogenomics ......................................................................... 25
Chapter3 5:3Pharmacology3 Across3 the3Life3Span ................................................................................. 30
Chapter3 6:3Drug-Therapy3 Prescribing3in 3Special3 Populations.............................................................. 36
Chapter3 7:3Drug3Development3 and3Approval ..................................................................................... 45
Chapter38-Chapter310:3Foundations3of3Prescription3Writing3Chapter39:3ResponsibleControlled-
Substance3Prescribing3Chapter310:3Antibiotic3Stewardship.................................................................. 51
Chapter3 11:3 Applied3Calculations3 for3 Prescribing .............................................................................. 58
Chapter312-:3Promoting3Adherence3With3Pharmacotherapy3II:3System-Specific3and3Patient-
Focused3Prescribing3Chapter313:3Pharmacotherapy3for3Ear,3Nose,3Mouth,3andThroat3Conditions3/Chapte
r314:3Pharmacotherapy3for3 Eye3Conditions......................................................................................... 67
Chapter3 15:3 Pharmacotherapy3 for3 Skin3 Conditions............................................................................. 74
Chapter3 16:3Pharmacotherapy3 for3 Neurologic3 Conditions ................................................................... 81
Chapter3 17:3 Pharmacotherapy3 for3 Cardiovascular3 Conditions ............................................................. 94
Chapter3 18:3 Pharmacotherapy3 for3 Respiratory3 Conditions ................................................................ 106
Chapter319:3Pharmacotherapy3for3Gastrointestinal3Conditions3and3Conditions3RequiringNutritional3Supp
ort .................................................................................................................................................. 117
Chapter3 20:3Pharmacotherapy3 for3 Genitourinary3 Conditions ............................................................. 128
Chapter3 21:3 Pharmacotherapy3for3 Renal,3 Acid–Base,3 Fluid,3 and3Electrolyte3Disorders...................... 133
Chapter3 22:3 Pharmacotherapy3 for3 Musculoskeletal3 and3 Rheumatologic3 Conditions ........................... 146
Chapter3 23:3 Therapeutic3 Applications3 of3 Immunology3 and3 Vaccines................................................ 158
Chapter3 24:3Pharmacotherapy3 for3 Endocrine3 Disorders .................................................................... 163
Chapter3 25:3Pharmacotherapy3 for3 Hematologic3 Disorders ................................................................ 174
Chapter3 26:3 Hematology/Oncology3and3Supportive3 Care3for3 the3Nononcologist................................ 190
Chapter3 27:3Pharmacotherapy3 Related3 to3 Women’s3 Health3Conditions ............................................. 196
Chapter3 28:3 Pharmacotherapy3 Related3 to3 Men’s3 Health3 Conditions .................................................. 211
Chapter3 29:3Pharmacotherapy3 Related3 to3Transgender3 Care ............................................................. 217
Chapter3 30:3 Antimicrobial3 Pharmacotherapy .................................................................................... 224
Chapter3 31:3 Antiretroviral3 Pharmacotherapy .................................................................................... 235
Chapter332:3Psychopharmacology3and3Integrative3Health:3Combined3Treatment3ofPsychiatric3and3Neuro
cognitive3Conditions........................................................................................................................ 247
Chapter3 33:3Pharmacotherapy3for3 Pain3Management ........................................................................ 257
Chapter3 34:3Substance3 Use3Disorder3 III:3Health3Promotion3and3Maintenance ................................... 267
Chapter3 35:3Over-the-Counter3 Medications ...................................................................................... 283
Chapter3 36:3Pharmacotherapy3for3 Obesity ....................................................................................... 291
,Chapter31:3An3Introduction3 to3Evidence-Based3Clinical3Practice3Guidelines
MULTIPLE3CHOICE
• What3is3the3 primary3 purpose3 of3 the3nursing3 assessment?
A. Identifying3 underlying3 pathologic3 conditions
B. Assisting3 the3 physician3 in3identifying3 medical3 conditions
C. Determining3 the3 patients3 mental3status
D. Exploring 3 patient3 responses3 to3 health3 problems
ANS:3D
A3nursing3assessment3is3done3to3identify3the3patients3response3to3health3p
roblems.3During3the3nursing3assessment3phase,3a3comprehensive3informat
ion3base3is3developed3through3a3physical3examination,3nursing3history,3m
edication3history,3and3professional3observation.3Identifying3underlying 3pat
hologic3conditions3and3assisting3the3physician3in3identifying3medical3con
ditions3is3not3part3of3the3nursing3process.3Determining3the3patients3 mental
3status3 is3 one3part3 of3the3 nursing 3 assessment,3 but3 it3 is3 not3the3primary 3p
urpose.
DIF:3Cognitive3Level:3Comprehension
3REF:3dm336 3OBJ:31 3|33 3TOP:3Nursin
g3Process3Step:3Assessment
MSC:3NCLEX3 Client3 Needs3 Category:3 Health3 Promotion3 and3 Maintenance
• What3is3the3 basis3 of3the3NANDA3I3 taxonomy?
A. Functional3 health3patterns
B. Human3 response3patterns
C. Basic3 human3 needs
D. Pathophysiologic3 needs
ANS:3B
The3 NANDA3 I3 taxonomy3 identifies3 human3 response3 patterns.3Functio
nal3components3of3health3patterns3are3limited3to3activity,3fluid3volume,3n
utrition,3self3care,3and3sensory3perception.3Basic3human3needs3comprise3
less3than3merely3health3patterns.3Pathophysiologic3needs3are3 not3part3of
3the3scope3of3NANDA 3I.
, DIF:3Cognitive3Level:3 Knowledge3RE
F:3pp.337-383OBJ:353TOP:
Nursing3Process3Step:3Diagnosis
MSC:3NCLEX3 Client3 Needs3 Category:3 Physiological3 Integrity
• Which3task3 is3included3 in3the3 assessment3 step3of3the3 nursing3 process?
A. Establishing3 patient3 goals/outcomes
B. Implementing3 the3 nursing3 care3 plan3 (NCP)
C. Measuring3 goal/outcome3 achievement
D. Collecting3 and3 communicating3 data
ANS:3D
Data3are3collected3and3communicated3in3the3assessment3phase3of3the3nurs
ing3process.3Establishing3goals3is3the3function3of3planning.
Implementing 3the3NCP3is3the3function3of3implementation.3Measuring3out
come3achievement3is3the3function3of3evaluation.
DIF:3Cognitive3Level:3Comprehension
3REF:3dm336 3OBJ:32 3|33 3TOP:3Nursin
g3Process3Step:3Assessment
MSC:3NCLEX3 Client3 Needs3 Category:3 Health3 Promotion3 and3 Maintenance
• Which3statement3 regarding3 nursing3diagnoses3 is3 accurate?
a. Nursing3diagnoses3 remain3the3same3 for3 as3 long3as3 the3disease3 is3 present.
b. Nursing3 diagnoses3 are3 written3 to3 identify3disease3states.
c. Nursing3diagnoses3 describe3 patient3 problems3 that3 nurses3 treat.
d. Nursing3 diagnoses3 identify3 causes3 related3 to3 illness.
ANS:3C
Diagnostic3statements3identify3problems3a3nurse3is3independently 3able3to3
treat3within3the3scope3of3professional3practice.3Nursing3diagnoses3vary3w
ith3the3changing3condition3of3the3patient.3The3response3patterns3are3uniqu
e3to3the3patient3and3are3not3disease3specific.3Nursing3diagnoses3describe3t
he3patients3human3response3pattern.
DIF:3 Cognitive3 Level:3 Comprehension
